Breast Cancer

Study Supports Using MRD as a Stratification Variable for Patients with TNBC
August 12, 2020
ByHannah Slater

Researchers suggested that these findings support using minimal residual disease as a major stratification variable in all clinical trials to be conducted in patients with triple negative breast cancer.

Study Finds Impact of Surgical Delay on Women with Breast Cancer Due to COVID-19
August 12, 2020
ByHannah Slater

These study results suggested that a longer time to surgery does not lower overall survival for women with early-stage breast cancer who had to delay operations due to the COVID-19 pandemic.

Phase 3 IMpassion131 Study Fails to Meet Primary End Point of PFS in Metastatic TNBC
August 07, 2020
ByHannah Slater

The study evaluating atezolizumab in combination with paclitaxel compared to placebo plus paclitaxel did not meet its primary end point of progression-free survival in patients with metastatic triple-negative breast cancer.